Abstract Background SARS-CoV-2, which majorly affects the lungs and respiratory tract is
thought due to dysregulation of the immune system which causes an immense imbalance of …

Recent research has demonstrated that mesenchymal stem cells (MSCs) potentially benefit
and enhance coronavirus disease (COVID-19) recovery. This benefit occurs via a …

The COVID-19 disease, which is caused by the novel coronavirus, SARS-CoV-2, has
affected the world by increasing the mortality rate in 2020. Currently, there is no definite …

Background Global pandemic identified as coronavirus disease 2019 (COVID-19) has
resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe …

Background Long-term effects of human mesenchymal stem cell (MSC) treatment on COVID-
19 patients have not been fully characterized. The aim of this study was to evaluate the …

SARS-CoV-2 is a novel Betacoronavirus species that has caused the coronavirus disease
2019 (COVID-19) pandemic. At the moment, there is no definite or unified treatment protocol …

In many countries, COVID-19 now accounts for more deaths per year than car accidents and
even the deadliest wars. Combating the viral pandemics requires a coordinated effort to …

Currently, the world is facing the SARS-CoV-2 pandemic, coronavirus of acute respiratory
distress syndrome 2, causes of COVID-19. Coronaviruses are RNA single-stranded viruses …

Immunomodulatory therapeutic approaches such as glucocorticoid therapy, convalescent
plasma therapy, and antiinterleukin (IL-6) receptor antibody therapy have been used for the …

Abstract Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia
associated with rapid virus replication. Arising in Wuhan China December 2019, the current …